Interferon-driven alterations of the host’s amino acid metabolism in the pathogenesis of typhoid fever
Christoph J. Blohmke, Andrew J. Pollard(University of Oxford), Marcelo B. Sztein(University of Maryland, Baltimore), Jyoti S. Choudhary(Institute of Cancer Research), Maria A. Duque‐Correa(University of Cambridge), Fernanda Schreiber(Wellcome Sanger Institute), Thomas C. Darton(Sheffield Teaching Hospitals NHS Foundation Trust), Milensu Shanyinde(University of Oxford), Robert A. Kingsley(University of East Anglia), Nicolás M. Suárez(Nationwide Children's Hospital), Stephen Lockhart(Johns Hopkins University), Leanne Kane(Wellcome Sanger Institute), Myron M. Levine(University of Maryland, Baltimore), Octavio Ramilo(St. Jude Children's Research Hospital), James C. Wright(Institute of Cancer Research), Claire S. Waddington(University of Oxford), Theodoros I. Roumeliotis(Institute of Cancer Research), Subhankar Mukhopadhyay(Wellcome Sanger Institute), Jennifer Hill(University of Oxford), Lu Yu(Hubei University of Medicine), David J. Lynn(Flinders University), Simon Clare(University of Cambridge), Liqing Zhou(National Institute for Health and Care Research), Claire Jones(National Institute for Health and Care Research), Brian Angus(University of Oxford), Gordon Dougan(University of Cambridge), Asunción Mejías(St. Jude Children's Research Hospital)
Cited by 51
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k